Search
for
Sort by
Research 30 of 1000+
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Inheritance-Specific Dysregulation of Th1- and Th17-Associated Cytokines in Alopecia Areata
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Alopecia Areata: Current Treatments and New Directions
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Autoimmunity and autoimmune co-morbidities in psoriasis
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- New and Emerging Therapies for Alopecia Areata
- MicroRNA-1246 Inhibits NFATc1 Phosphorylation and Regulates T Helper 17 Cell Activation in the Pathogenesis of Severe Alopecia Areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management